126 related articles for article (PubMed ID: 3410375)
21. Effect of methylcarbonylmethyl 2(S)-[4-(4-guanidino-benzoyloxy)phenyl] propionate methanesulfonate (TT-S24) on experimental pancreatitis in rats.
Tagami H; Abe S; Yoshida Y; Tanaka I; Kamei C
Biol Pharm Bull; 1998 Mar; 21(3):227-30. PubMed ID: 9556150
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic effect of a new synthetic protease inhibitor (E-3123) on hemodynamic changes during experimental acute pancreatitis in dogs.
Satake K; Ha SS; Hiura A; Nishiwaki H
Gastroenterol Jpn; 1993 Feb; 28(1):64-71. PubMed ID: 8440425
[TBL] [Abstract][Full Text] [Related]
23. Effect of a new synthetic trypsin inhibitor on taurocholate-induced acute pancreatitis in rats.
Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y
Pancreas; 1993 Mar; 8(2):240-7. PubMed ID: 8460097
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
Aoyama T; Ino Y; Ozeki M; Oda M; Sato T; Koshiyama Y; Suzuki S; Fujita M
Jpn J Pharmacol; 1984 Jul; 35(3):203-27. PubMed ID: 6482087
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of continuous arterial infusion of an antibiotic and a protease inhibitor via the superior mesenteric artery for acute pancreatitis in an animal model.
Takagi K; Isaji S
Pancreas; 2000 Oct; 21(3):279-89. PubMed ID: 11039473
[TBL] [Abstract][Full Text] [Related]
26. Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis.
Kakugawa Y; Takeda K; Kobari M; Matsuno S
Gastroenterol Jpn; 1989 Aug; 24(4):448. PubMed ID: 2777022
[No Abstract] [Full Text] [Related]
27. Effect of a new synthetic protease inhibitor on beta-endorphin release during acute pancreatitis in dogs.
Satake K; Hiura A; Ha SS; Nishiwaki H; Umeyama K
Pancreas; 1991 Jul; 6(4):441-7. PubMed ID: 1876600
[TBL] [Abstract][Full Text] [Related]
28. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
Wakayama T; Itoh T; Shibayama K; Idezuki Y
Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
[TBL] [Abstract][Full Text] [Related]
29. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?
Park KT; Kang DH; Choi CW; Cho M; Park SB; Kim HW; Kim DU; Chung CW; Yoon KT
Pancreas; 2011 Nov; 40(8):1215-9. PubMed ID: 21775918
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
[TBL] [Abstract][Full Text] [Related]
31. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis.
Paszkowski AS; Rau B; Mayer JM; Möller P; Beger HG
Ann Surg; 2002 Jan; 235(1):68-76. PubMed ID: 11753044
[TBL] [Abstract][Full Text] [Related]
33. Oral administration of sepimostat mesilate prevents acute alcohol pancreatic injury in rats.
Yuasa C; Irimura K; Oda M; Fukui K; Oka T
J Pharm Pharmacol; 1999 Jul; 51(7):867-71. PubMed ID: 10467964
[TBL] [Abstract][Full Text] [Related]
34. Toxic products in hemorrhagic ascitic fluid generated during experimental acute hemorrhagic pancreatitis in dogs and a treatment which reduces their effect.
Satake K; Koh I; Nishiwaki H; Umeyama K
Digestion; 1985; 32(2):99-105. PubMed ID: 4043568
[TBL] [Abstract][Full Text] [Related]
35. Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
Keck T; Balcom JH; Antoniu BA; Lewandrowski K; Warshaw AL; Fernández-del Castillo CF
Surgery; 2001 Aug; 130(2):175-81. PubMed ID: 11490346
[TBL] [Abstract][Full Text] [Related]
36. Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175).
Lukaszyk A; Bodzenta-Lukaszyk A; Gabryelewicz A; Bielawiec M
Thromb Res; 1992 Jan; 65(2):229-39. PubMed ID: 1579898
[TBL] [Abstract][Full Text] [Related]
37. Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis.
Ohshio G; Saluja AK; Leli U; Sengupta A; Steer ML
Gastroenterology; 1989 Mar; 96(3):853-9. PubMed ID: 2464526
[TBL] [Abstract][Full Text] [Related]
38. Effects of a newly synthesized pancreatic protease inhibitor (PATM) on pancreatic microcirculation in experimental acute pancreatitis.
Nishiwaki H; Satake K; Hiura A; Umeyama K
Gastroenterol Jpn; 1989 Apr; 24(2):177-80. PubMed ID: 2744334
[TBL] [Abstract][Full Text] [Related]
39. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis.
Dobosz M; Sledziński Z; Basiński A; Stanek A; Babicki A; Wajda Z
Res Exp Med (Berl); 1989; 189(2):77-84. PubMed ID: 2499022
[TBL] [Abstract][Full Text] [Related]
40. Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs.
Satake K; Ha S; Hiura A; Nishiwaki H; Haku A; Umeyama K
Gastroenterol Jpn; 1990 Dec; 25(6):720-6. PubMed ID: 2279634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
